线粒体DNA碱基编辑技术研究进展
收稿日期: 2023-03-01
修回日期: 2023-06-21
网络出版日期: 2023-07-04
基金资助
国家重点研发计划项目(2021YFC2700600);国家自然科学基金项目(31970796)
Advances in mitochondrial DNA base editing technology
Received date: 2023-03-01
Revised date: 2023-06-21
Online published: 2023-07-04
Supported by
National Key R&D Program of China(2021YFC2700600);National Natural Science Foundation of China(31970796)
线粒体作为真核高等生物的能量工厂,通过有氧呼吸的方式为各项生命活动提供能量(ATP)。线粒体拥有一套独立于细胞核的基因组——线粒体DNA(mitochondrial DNA,mtDNA),编码37个基因,其突变会导致线粒体疾病,目前已在人mtDNA中鉴定出了超过100种致病突变位点,总发病率约为1/5000。近年来,基于CRISPR的碱基编辑技术已经实现了对核基因组的精确编辑,然而由于CRISPR系统中的引导RNA难以通过线粒体的双层膜结构,在mtDNA上实现精确的碱基编辑仍具有较大的挑战性。2020年,美国哈佛大学David R. Liu实验室报道了一种伯克霍尔德氏菌来源的双链DNA脱氨酶DddA,将其与可编程的转录激活样效应因子(transcription activator-like effector,TALE)和尿嘧啶糖苷酶抑制剂(uracil glycosylase inhibitor,UGI)融合组装成为DdCBEs(DddA来源的胞嘧啶碱基编辑器),首次在mtDNA上实现了特异高效的C·G到T·A的转换。本文对近几年基于DddA的线粒体碱基编辑技术的发展进行综述,并对其未来应用前景进行展望,以期为相关领域的科研人员进一步了解、使用及优化线粒体碱基编辑技术提供参考。
宋睿嘉, 韩露, 孙海峰, 沈彬 . 线粒体DNA碱基编辑技术研究进展[J]. 遗传, 2023 , 45(8) : 632 -642 . DOI: 10.16288/j.yczz.23-045
Mitochondria, the energy factories of higher eukaryotes, provide energy (ATP) for life activities through aerobic respiration. They possess their own genome, mitochondrial DNA (mtDNA), which encodes 37 genes. Mutations in mtDNA cause mitochondrial diseases, and more than 100 pathogenic mutations have been identified in human mtDNA, with a total incidence rate of about 1/5000. In recent years, advances in CRISPR-based base editing technology have enabled accurate editing of nuclear genes. However, it remains a challenge to achieve precise base editing on mtDNA due to the difficulty of guide RNA in the CRISPR system passing through the mitochondrial double-membrane. In 2020, David R. Liu’s group at Harvard University reported a double-stranded DNA deaminase DddA from Burkholderia cenocepacia, which was fused with the programmable transcription activator-like effector (TALE) and uracil glycosylase inhibitor (UGI) to develop DddA-derived cytosine base editors (DdCBEs). Using DdCBEs, they were able to achieve specific and efficient C?G to T?A conversion on mtDNA for the first time. In this review, we summarize the recent progress of mitochondrial base editing technology based on DddA and prospect its future application prospects. The information presented may facilitate interested researchers to grasp the principles of mitochondrial base editing, to use relevant base editors in their own studies, or to optimize mitochondrial base editors in the future.
Key words: mitochondrial DNA; base editing; mitochondrial diseases
| [1] | Jia ZW. Mitochondria and pluripotent stem cells function. Hereditas(Beijing), 2016, 38(7): 603-611. |
| [1] | 贾振伟. 线粒体与多潜能干细胞功能. 遗传, 2016, 38(7): 603-611. |
| [2] | Tuppen HAL, Blakely EL, Turnbull DM, Taylor RW. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta, 2010, 1797(2): 113-128. |
| [3] | Neupert W. SnapShot: mitochondrial architecture. Cell, 2012, 149(3): 722-722.e1. |
| [4] | Schatz G. Mitochondrial DNA. In:Encyclopedia of biological chemistry. Elsevier, 2013, 132-134. |
| [5] | Gray MW. Mitochondrial DNA. In:Brenner’s encyclopedia of genetics. Elsevier, 2013, 436-438. |
| [6] | Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG. Sequence and organization of the human mitochondrial genome. Nature, 1981, 290(5806): 457-465. |
| [7] | Ziada AS, Smith MSR, C?té HCF. Updating the free radical theory of aging. Front Cell Dev Biol, 2020, 8: 575645. |
| [8] | Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet, 2005, 6(5): 389-402. |
| [9] | Biesalski HK. Free radical theory of aging. Curr Opin Clin Nutr Metab Care, 2002, 5(1): 5-10. |
| [10] | Filograna R, Mennuni M, Alsina D, Larsson NG. Mitochondrial DNA copy number in human disease: the more the better? FEBS Lett, 2021, 595(8): 976-1002. |
| [11] | Silva-Pinheiro P, Minczuk M. The potential of mitochondrial genome engineering. Nat Rev Genet, 2022, 23(4): 199-214. |
| [12] | Gammage PA, Moraes CT, Minczuk M. Mitochondrial genome engineering: the revolution may not be CRISPR-Ized. Trends Genet, 2018, 34(2): 101-110. |
| [13] | Pinheiro P, Gammage PA, Minczuk M. Mitochondrially targeted zinc finger nucleases. In: The human mitochondrial genome. Elsevier, 2020, 499-514. |
| [14] | Gammage PA, Rorbach J, Vincent AI, Rebar EJ, Minczuk M. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large- scale deletions or point mutations. EMBO Mol Med, 2014, 6(4): 458-466. |
| [15] | Gammage PA, Viscomi C, Simard ML, Costa ASH, Gaude E, Powell CA, Van Haute L, McCann BJ, Rebelo-Guiomar P, Cerutti R, Zhang L, Rebar EJ, Zeviani M, Frezza C, Stewart JB, Minczuk M. Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo. Nat Med, 2018, 24(11): 1691-1695. |
| [16] | Gammage PA, Gaude E, Van Haute L, Rebelo-Guiomar P, Jackson CB, Rorbach J, Pekalski ML, Robinson AJ, Charpentier M, Concordet JP, Frezza C, Minczuk M. Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs. Nucleic Acids Res, 2016, 44(16): 7804-7816. |
| [17] | McCann BJ, Cox A, Gammage PA, Stewart JB, Zernicka-Goetz M, Minczuk M. Delivery of mtZFNs into early mouse embryos. In: Liu J (ed). Zinc Finger Proteins, vol. 1867. New York, NY: Springer New York, 2018, 215-228. |
| [18] | Minczuk M. Engineered zinc finger proteins for manipulation of the human mitochondrial genome. In: Mackay JP, Segal DJ eds. Engineered Zinc Finger Proteins vol. 649. Totowa, NJ: Humana Press, 2010, 257-270. |
| [19] | Gammage PA, Van Haute L, Minczuk M. Engineered mtZFNs for manipulation of human mitochondrial DNA heteroplasmy. In: McKenzie M ed. MitochondrialDNA, vol. 1351. New York, NY: Springer New York, 2016, 145-162. |
| [20] | Reddy P, Ocampo A, Suzuki K, Luo JP, Bacman SR, Williams SL, Sugawara A, Okamura D, Tsunekawa Y, Wu J, Lam D, Xiong X, Montserrat N, Esteban CR, Liu GH, Sancho-Martinez I, Manau D, Civico S, Cardellach F, del Mar O’Callaghan M, Campistol J, Zhao HM, Campistol JM, Moraes CT, Izpisua Belmonte JC. Selective elimination of mitochondrial mutations in the germline by genome editing. Cell, 2015, 161(3): 459-469. |
| [21] | Hashimoto M, Bacman SR, Peralta S, Falk MJ, Chomyn A, Chan DC, Williams SL, Moraes CT. MitoTALEN: A general approach to reduce mutant mtDNA loads and restore oxidative phosphorylation function in mitochondrial diseases. Mol Ther, 2015, 23(10): 1592-1599. |
| [22] | Bacman SR, Gammage PA, Minczuk M, Moraes CT. Manipulation of mitochondrial genes and mtDNA heteroplasmy. In: Methods in cell biology vol. 155. Elsevier, 2020, 441-487. |
| [23] | Bacman SR, Kauppila JHK, Pereira CV, Nissanka N, Miranda M, Pinto M, Williams SL, Larsson NG, Stewart JB, Moraes CT. MitoTALEN reduces mutant mtDNA load and restores TRNAAla levels in a mouse model of heteroplasmic mtDNA mutation. Nat Med, 2018, 24(11): 1696-1700. |
| [24] | Bacman SR, Williams SL, Pinto M, Peralta S, Moraes CT. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat Med, 2013, 19(9): 1111-1113. |
| [25] | Mikhailov N, H?m?l?inen RH. Modulating mitochondrial DNA heteroplasmy with mitochondrially targeted endonucleases. Ann Biomed Eng, 2022, doi: 10.1007/s10439-022-03051-7. |
| [26] | Rees HA, Liu DR. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet, 2018, 19(12): 770-788. |
| [27] | Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 2016, 533(7603): 420-424. |
| [28] | Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR. Programmable base editing of A?T to G?C in genomic DNA without DNA cleavage. Nature, 2017, 551(7681): 464-471. |
| [29] | Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, Mochizuki M, Miyabe A, Araki M, Hara KY, Shimatani Z, Kondo A. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science, 2016, 353(6305): aaf8729. |
| [30] | Mok BY, de Moraes MH, Zeng J, Bosch DE, Kotrys AV, Raguram A, Hsu F, Radey MC, Peterson SB, Mootha VK, Mougous JD, Liu DR. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature, 2020, 583(7817): 631-637. |
| [31] | Krokan HE, Bj?r?s M. Base excision repair. Cold Spring Harb Perspect Biol, 2013, 5(4): a012583. |
| [32] | Aushev M, Herbert M. Mitochondrial Genome Editing Gets Precise. Nature, 2020, 583(7817): 521-522. |
| [33] | Barrera-Paez JD, Moraes CT. Mitochondrial genome engineering coming-of-age. Trends Genet, 2022, 38(8): 869-880. |
| [34] | Bi R, Li Y, Xu M, Zheng QZ, Zhang DF, Li X, Ma GL, Xiang BL, Zhu XJ, Zhao H, Huang XX, Zheng P, Yao YG. Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing. Innovation (Camb), 2022, 3(6): 100329. |
| [35] | Riepsaame J. Editing the mitochondrial genome: no CRISPR required. Trends Genet, 2020, 36(11): 809-810. |
| [36] | Lee H, Lee S, Baek G, Kim A, Kang BC, Seo H, Kim JS. Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases. Nat Commun, 2021, 12(1): 1190. |
| [37] | Guo JY, Chen XX, Liu ZW, Sun HF, Zhou Y, Dai YC, Ma YE, He L, Qian XZ, Wang JY, Zhang J, Zhu YC, Zhang J, Shen B, Zhou F. DdCBE mediates efficient and inheritable modifications in mouse mitochondrial genome. Mol Ther Nucleic Acids, 2021, 27: 73-80. |
| [38] | Lee S, Lee H, Baek G, Namgung E, Park JM, Kim S, Hong S, Kim JS. Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases. Genome Biol, 2022, 23(1): 211. |
| [39] | Guo JY, Zhang X, Chen XX, Sun HF, Dai YC, Wang JY, Qian XZ, Tan L, Lou X, Shen B. Precision modeling of mitochondrial diseases in zebrafish via DdCBE-mediated mtDNA base editing. Cell Discov, 2021, 7(1): 78. |
| [40] | Qi XL, Chen XX, Guo JY, Zhang X, Sun HF, Wang JY, Qian XZ, Li B, Tan L, Yu L, Chen W, Zhang LF, Ma YW, Shen B. Precision modeling of mitochondrial disease in rats via DdCBE-mediated mtDNA editing. Cell Discov, 2021, 7(1): 95. |
| [41] | Chen YP, Lüttmann FF, Schoger E, Sch?ler HR, Zelarayán LC, Kim KP, Haigh JJ, Kim J, Braun T. Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice. Science, 2021, 373(6562): 1537-1540. |
| [42] | Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K, Bernard S, Sjostrom SL, Szewczykowska M, Jackowska T, Dos Remedios C, Malm T, Andr? M, Jashari R, Nyengaard JR, Possnert G, Jovinge S, Druid H, Frisén J. Dynamics of cell generation and turnover in the human heart. Cell, 2015, 161(7): 1566-1575. |
| [43] | Silva-Pinheiro P, Nash PA, Van Haute L, Mutti CD, Turner K, Minczuk M. In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue. Nat Commun, 2022, 13(1): 750. |
| [44] | Mok YG, Lee JM, Chung E, Lee J, Lim K, Cho SI, Kim JS. Base editing in human cells with monomeric DddA-TALE fusion deaminases. Nat Commun, 2022, 13(1): 4038. |
| [45] | Chen XX, Liang D, Guo JY, Zhang JQ, Sun HF, Zhang XL, Jin JC, Dai YC, Bao QM, Qian XZ, Tan L, Hu P, Ling XF, Shen B, Xu ZF. DdCBE-Mediated mitochondrial base editing in human 3PN embryos. Cell Discov, 2022, 8(1): 8. |
| [46] | St John JC, Facucho-Oliveira J, Jiang Y, Kelly R, Salah R. Mitochondrial DNA transmission, replication and inheritance: a journey from the gamete through the embryo and into offspring and embryonic stem cells. Hum Reprod Update, 2010, 16(5): 488-509. |
| [47] | Wei YH, Xu CL, Feng H, Xu K, Li ZF, Hu J, Zhou L, Wei Y, Zuo ZR, Zuo EW, Li W, Yang H, Zhang ML. Human cleaving embryos enable efficient mitochondrial base- editing with DdCBE. Cell Discov, 2022, 8(1): 7. |
| [48] | Wrighton KH. Cytosine base editors go off-target. Nat Rev Genet, 2019, 20(5): 254-255. |
| [49] | Zuo EW, Sun YD, Wei W, Yuan TL, Ying WQ, Sun H, Yuan LY, Steinmetz LM, Li YX, Yang H. GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos. Nat Protoc, 2020, 15(9): 3009-3029. |
| [50] | Zuo EW, Sun YD, Wei W, Yuan TL, Ying WQ, Sun H, Yuan LY, Steinmetz LM, Li YX, Yang H. Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science, 2019, 364(6437): 289-292. |
| [51] | Wei YH, Li ZF, Xu K, Feng H, Xie L, Li D, Zuo ZR, Zhang ML, Xu CL, Yang H, Zuo EW. Mitochondrial base editor DdCBE causes substantial DNA off-target editing in nuclear genome of embryos. Cell Discov, 2022, 8(1): 27. |
| [52] | Lei ZX, Meng HW, Lv ZC, Liu MH, Zhao HN, Wu H, Zhang XX, Liu LL, Zhuang Y, Yin KL, Yan YC, Yi CQ. Detect-seq reveals out-of-protospacer editing and target- strand editing by cytosine base editors. Nat Methods, 2021, 18(6): 643-651. |
| [53] | Lei ZX, Meng HW, Liu LL, Zhao HN, Rao XC, Yan YC, Wu H, Liu M, He AB, Yi CQ. Mitochondrial base editor induces substantial nuclear off-target mutations. Nature, 2022, 606(7915): 804-811. |
| [54] | Rowley MJ, Corces VG. Organizational principles of 3D genome architecture. Nat Rev Genet, 2018, 19(12): 789-800. |
| [55] | Hansen AS, Pustova I, Cattoglio C, Tjian R, Darzacq X. CTCF and cohesin regulate chromatin loop stability with distinct dynamics. eLife, 2017, 6: e25776. |
| [56] | Lee S, Lee H, Baek G, Kim JS. Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors. Nat Biotechnol, 2023, 41(3): 378-386. |
| [57] | Miller JC, Holmes MC, Wang JB, Guschin DY, Lee YL, Rupniewski I, Beausejour CM, Waite AJ, Wang NS, Kim KA, Gregory PD, Pabo CO, Rebar EJ. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol, 2007, 25(7): 778-785. |
| [58] | Szczepek M, Brondani V, Büchel J, Serrano L, Segal DJ, Cathomen T. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol, 2007, 25(7): 786-793. |
| [59] | Mok BY, Kotrys AV, Raguram A, Huang TP, Mootha VK, Liu DR. CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA. Nat Biotechnol, 2022, 40(9): 1378-1387. |
| [60] | Thuronyi BW, Koblan LW, Levy JM, Yeh WH, Zheng C, Newby GA, Wilson C, Bhaumik M, Shubina-Oleinik O, Holt JR, Liu DR. Continuous evolution of base editors with expanded target compatibility and improved activity. Nat Biotechnol, 2019, 37(9): 1070-1079. |
| [61] | Roth TB, Woolston BM, Stephanopoulos G, Liu DR.Phage-assisted evolution of bacillus methanolicus methanol dehydrogenase 2. Acs Synth Biol, 2019, 8(4): 796-806. |
| [62] | Dickinson BC, Packer MS, Badran AH, Liu DR. A system for the continuous directed evolution of proteases rapidly reveals drug-resistance mutations. Nat Commun, 2014, 5(1): 5352. |
| [63] | Cho SI, Lee S, Mok YG, Lim K, Lee J, Lee JM, Chung E, Kim JS. Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases. Cell, 2022, 185(10): 1764-1776.e12. |
| [64] | Richter MF, Zhao KT, Eton E, Lapinaite A, Newby GA, Thuronyi BW, Wilson C, Koblan LW, Zeng J, Bauer DE, Doudna JA, Liu DR. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat Biotechnol, 2020, 38(7): 883-891. |
| [65] | Morgan MA, Lange L, Schambach A. Prime time for base editing in the mitochondria. Signal Transduct Target Ther, 2022, 7(1): 213. |
| [66] | Willis JCW, Silva-Pinheiro P, Widdup L, Minczuk M, Liu DR. Compact zinc finger base editors that edit mitochondrial or nuclear DNA in vitro and in vivo. Nat Commun, 2022, 13(1): 7204. |
| [67] | Lim K, Cho SI, Kim JS. Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases. Nat Commun, 2022, 13(1): 366. |
| [68] | Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ, Wilson C, Newby GA, Raguram A, Liu DR. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 2019, 576(7785): 149-157. |
| [69] | Chen PJ, Liu DR. Prime editing for precise and highly versatile genome manipulation. Nat Rev Genet, 2023, 24(3): 161-177. |
| [70] | Zong Y, Gao CX. Progress on base editing systems. Hereditas(Beijing), 2019, 41(9): 777-800. |
| [70] | 宗媛, 高彩霞. 碱基编辑系统研究进展. 遗传, 2019, 41(9): 777-800. |
/
| 〈 |
|
〉 |